Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea

View source ↗

Summary

Clinical trial update for OBIZUR in adults with Acquired Hemophilia A in South Korea shows the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OBIZUR (recombinant porcine factor VIII (rpFVIII))

Snippet

Sponsor: Takeda | Conditions: Acquired Hemophilia A | Status: RECRUITING